Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$21.0 - $29.1 $4,053 - $5,616
193 New
193 $4,000
Q4 2022

Feb 14, 2023

SELL
$15.31 - $29.94 $2.04 Million - $4 Million
-133,528 Reduced 91.14%
12,974 $307,000
Q3 2022

Nov 14, 2022

BUY
$16.58 - $27.9 $2.32 Million - $3.9 Million
139,677 Added 2046.55%
146,502 $2.43 Million
Q2 2022

Aug 08, 2022

BUY
$15.45 - $29.52 $105,446 - $201,474
6,825 New
6,825 $136,000
Q4 2021

Feb 11, 2022

SELL
$36.09 - $53.79 $1,912 - $2,850
-53 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$35.62 - $52.97 $1,887 - $2,807
53 New
53 $2,000
Q2 2021

Aug 09, 2021

SELL
$32.94 - $56.62 $221,225 - $380,259
-6,716 Closed
0 $0
Q1 2021

Apr 28, 2021

BUY
$44.47 - $81.38 $298,660 - $546,548
6,716 New
6,716 $359,000
Q4 2020

Feb 09, 2021

SELL
$32.49 - $61.88 $149,389 - $284,524
-4,598 Closed
0 $0
Q3 2020

Nov 02, 2020

BUY
$26.73 - $35.67 $118,333 - $157,911
4,427 Added 2588.89%
4,598 $150,000
Q2 2020

Aug 11, 2020

SELL
$19.49 - $28.11 $3,508 - $5,059
-180 Reduced 51.28%
171 $4,000
Q1 2020

May 15, 2020

SELL
$16.13 - $30.17 $76,214 - $142,553
-4,725 Reduced 93.09%
351 $9,000
Q4 2019

Feb 13, 2020

BUY
$20.78 - $29.99 $105,479 - $152,229
5,076 New
5,076 $141,000
Q3 2019

Oct 17, 2019

SELL
$23.87 - $30.93 $146,370 - $189,662
-6,132 Closed
0 $0
Q1 2019

Apr 16, 2019

SELL
$12.0 - $25.76 $3,600 - $7,728
-300 Reduced 4.66%
6,132 $153,000
Q4 2018

Jan 17, 2019

SELL
$9.15 - $14.85 $89,175 - $144,728
-9,746 Reduced 60.24%
6,432 $80,000
Q3 2018

Nov 02, 2018

BUY
$9.55 - $12.64 $68,588 - $90,780
7,182 Added 79.84%
16,178 $0
Q2 2018

Jul 24, 2018

BUY
$5.39 - $9.66 $26,998 - $48,386
5,009 Added 125.63%
8,996 $0
Q1 2018

May 03, 2018

BUY
$5.44 - $6.97 $5,342 - $6,844
982 Added 32.68%
3,987 $22,000
Q4 2017

Feb 02, 2018

BUY
$6.05 - $9.37 $10,678 - $16,538
1,765 Added 142.34%
3,005 $20,000
Q3 2017

Oct 20, 2017

BUY
$7.81 - $8.77 $9,684 - $10,874
1,240
1,240 $11,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.97B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.